Nab-paclitaxel for the management of triple-negative metastatic breast cancer: a case study

per Arpino, Grazia, De Placido, Sabino, De Angelis, Carmine
Publicat a Anticancer Drugs (2015)

ESR1 mutations as a mechanism for acquired endocrine resistance in breast cancer

per Jeselsohn, Rinath, Buchwalter, Gilles, De Angelis, Carmine, Brown, Myles, Schiff, Rachel
Publicat a Nat Rev Clin Oncol (2015)

The Changing Role of ER in Endocrine Resistance

per Nardone, Agostina, De Angelis, Carmine, Trivedi, Meghana V., Osborne, C. Kent, Schiff, Rachel
Publicat a Breast (2015)

PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells

per Ito, Koichi, Park, Sun Hee, Katsyv, Igor, Zhang, Weijia, De Angelis, Carmine, Schiff, Rachel, Irie, Hanna Y.
Publicat a NPJ Breast Cancer (2017)

Towards personalized treatment for early stage HER2-positive breast cancer

per Goutsouliak, Kristina, Veeraraghavan, Jamunarani, Sethunath, Vidyalakshmi, De Angelis, Carmine, Osborne, C. Kent, Rimawi, Mothaffar F., Schiff, Rachel
Publicat a Nat Rev Clin Oncol (2019)

Immune Response Against Head and Neck Cancer: Biological Mechanisms and Implication on Therapy

per Perri, Francesco, Ionna, Franco, Longo, Francesco, Della Vittoria Scarpati, Giuseppina, De Angelis, Carmine, Ottaiano, Alessandro, Botti, Gerardo, Caponigro, Francesco
Publicat a Transl Oncol (2019)

De-escalation of treatment in HER2-positive breast cancer: Determinants of response and mechanisms of resistance

per Veeraraghavan, Jamunarani, De Angelis, Carmine, Reis-Filho, Jorge S., Prat, Aleix, Rimawi, Mothaffar F., Pascual, Tomás, Osborne, C. Kent, Schiff, Rachel
Publicat a Breast (2017)

What Medical Oncologist Residents Think about the Italian Speciality Schools: A Survey of the Italian Association of Medical Oncology (AIOM) on Educational, Clinical and Research A...

per Moretti, Anna, Ghidini, Michele, De Angelis, Carmine, Lambertini, Matteo, Cremolini, Chiara, Imbimbo, Martina, Berardi, Rossana, Di Maio, Massimo, Cascinu, Stefano, La Verde, Nicla
Publicat a PLoS One (2016)

Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer

per Guarducci, Cristina, Bonechi, Martina, Benelli, Matteo, Biagioni, Chiara, Boccalini, Giulia, Romagnoli, Dario, Verardo, Roberto, Schiff, Rachel, Osborne, C. Kent, De Angelis, Carmine, Di Leo, Angelo, Malorni, Luca, Migliaccio, Ilenia
Publicat a NPJ Breast Cancer (2018)

A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2-positive breast cancer

per Abdulkareem, Noor Mazin, Bhat, Raksha, Qin, Lanfang, Vasaikar, Suhas, Gopinathan, Ambily, Mitchell, Tamika, Shea, Martin J., Nanda, Sarmistha, Thangavel, Hariprasad, Zhang, Bing, De Angelis, Carmine, Schiff, Rachel, Trivedi, Meghana V.
Publicat a FASEB J (2021)

Case Report: Detection of a Novel Germline PALB2 Deletion in a Young Woman With Hereditary Breast Cancer: When the Patient's Phenotype History Doesn't Lie

per De Angelis, Carmine, Nardelli, Carmela, Concolino, Paola, Pagliuca, Martina, Setaro, Mario, De Paolis, Elisa, De Placido, Pietro, Forestieri, Valeria, Scaglione, Giovanni Luca, Ranieri, Annalisa, Lombardo, Barbara, Pastore, Lucio, De Placido, Sabino, Capoluongo, Ettore
Publicat a Front Oncol (2021)

Luminal-like HER2-negative stage IA breast cancer: a multicenter retrospective study on long-term outcome with propensity score analysis

per De Angelis, Carmine, Di Maio, Massimo, Crispo, Anna, Giuliano, Mario, Schettini, Francesco, Bonotto, Marta, Gerratana, Lorenzo, Iacono, Donatella, Cinausero, Marika, Riccardi, Ferdinando, Ciancia, Giuseppe, De Laurentiis, Michelino, Puglisi, Fabio, De Placido, Sabino, Arpino, Grazia
Publicat a Oncotarget (2017)

Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 era

per Arpino, Grazia, De Angelis, Carmine, De Placido, Pietro, Pietroluongo, Erica, Formisano, Luigi, Bianco, Roberto, Fiore, Giovanni, Montella, Emma, Forestieri, Valeria, Lauria, Rossella, Cardalesi, Cinzia, Vozzella, Emilia Anna, Iervolino, Anna, Giuliano, Mario, De Placido, Sabino
Publicat a ESMO Open (2020)

Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy

per Arpino, Grazia, De Angelis, Carmine, Buono, Giuseppe, Colao, Annamaria, Giuliano, Mario, Malgieri, Simona, Cicala, Stefania, De Laurentiis, Michelino, Accurso, Antonello, Crispo, Anna, Limite, Gennaro, Lauria, Rossella, Veneziani, Bianca Maria, Forestieri, Valeria, Bruzzese, Dario, De Placido, Sabino
Publicat a Breast Cancer Res Treat (2015)

Estrogen-induced transcription at individual alleles is independent of receptor level and active conformation but can be modulated by coactivators activity

per Stossi, Fabio, Dandekar, Radhika D, Mancini, Maureen G, Gu, Guowei, Fuqua, Suzanne A W, Nardone, Agostina, De Angelis, Carmine, Fu, Xiaoyong, Schiff, Rachel, Bedford, Mark T, Xu, Wei, Johansson, Hans E, Stephan, Clifford C, Mancini, Michael A
Publicat a Nucleic Acids Res (2020)

Circulating tumor cell investigation in breast cancer patient-derived xenograft models by automated immunofluorescence staining, image acquisition, and single cell retrieval and an...

per Ramirez, Arturo B., Bhat, Raksha, Sahay, Debashish, De Angelis, Carmine, Thangavel, Hariprasad, Hedayatpour, Sina, Dobrolecki, Lacey E., Nardone, Agostina, Giuliano, Mario, Nagi, Chandandeep, Rimawi, Mothaffar, Osborne, C. Kent, Lewis, Michael T., Stilwell, Jackie L., Kaldjian, Eric P., Schiff, Rachel, Trivedi, Meghana V.
Publicat a BMC Cancer (2019)

GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancer

per Bhat, Raksha R., Yadav, Puja, Sahay, Debashish, Bhargava, Dharmendra K., Creighton, Chad J., Yazdanfard, Sahar, Al-rawi, Ahmed, Yadav, Vikas, Qin, Lanfang, Nanda, Sarmistha, Sethunath, Vidyalakshmi, Fu, Xiaoyong, De Angelis, Carmine, Narkar, Vihang A., Kent Osborne, C., Schiff, Rachel, Trivedi, Meghana V.
Publicat a Breast Cancer Res Treat (2018)

Combined effect of obesity and diabetes on early breast cancer outcome: a prospective observational study

per Buono, Giuseppe, Crispo, Anna, Giuliano, Mario, De Angelis, Carmine, Schettini, Francesco, Forestieri, Valeria, Lauria, Rossella, Pensabene, Matilde, De Laurentiis, Michelino, Augustin, Livia Silvia Adriana, Amore, Alfonso, D'Aiuto, Massimiliano, Tortoriello, Raffaele, Accurso, Antonello, Cavalcanti, Ernesta, Botti, Gerardo, Montella, Maurizio, De Placido, Sabino, Arpino, Grazia
Publicat a Oncotarget (2017)

The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance

per Nardone, Agostina, Weir, Hazel, Delpuech, Oona, Brown, Henry, De Angelis, Carmine, Cataldo, Maria Letizia, Fu, Xiaoyong, Shea, Martin J., Mitchell, Tamika, Veeraraghavan, Jamunarani, Nagi, Chandandeep, Pilling, Mark, Rimawi, Mothaffar F., Trivedi, Meghana, Hilsenbeck, Susan G., Chamness, Gary C., Jeselsohn, Rinath, Osborne, C. Kent, Schiff, Rachel
Publicat a Br J Cancer (2018)

Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance

per Malorni, Luca, Giuliano, Mario, Migliaccio, Ilenia, Wang, Tao, Creighton, Chad J., Lupien, Mathieu, Fu, Xiaoyong, Hilsenbeck, Susan G., Healy, Nuala, De Angelis, Carmine, Mazumdar, Abhijit, Trivedi, Meghana V., Massarweh, Suleiman, Gutierrez, Carolina, De Placido, Sabino, Jeselsohn, Rinath, Brown, Myles, Brown, Powel H., Osborne, C. Kent, Schiff, Rachel
Publicat a Mol Cancer Res (2016)